Niels Gyldenkerne

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3K citations · Full text

Neoadjuvant Therapy, Chemotherapy Versus Cetuximab, Medicine +7

<i>Thymidylate Synthase</i> and <i>Methylenetetrahydrofolate Reductase</i> Gene Polymorphism in Normal Tissue As Predictors of Fluorouracil Sensitivity

Anders Jakobsen, Jens Nederby Nielsen, Niels Gyldenkerne et al. · Journal of Clinical Oncology · 2005 · 189 citations · Full text

Automatic treatment planning improves the clinical quality of head and neck cancer treatment plans

Christian Rønn Hansen, A. Bertelsen, Irene Hazell et al. · Clinical and Translational Radiation Oncology · 2016 · 108 citations · Full text

Adaptive Radiotherapy, Automatic Treatment, Medicine +12

Contouring and dose calculation in head and neck cancer radiotherapy after reduction of metal artifacts in CT images

Christian Rønn Hansen, Rasmus Lübeck Christiansen, Ebbe Laugaard Lorenzen et al. · Acta Oncologica · 2017 · 38 citations · Full text

Delineation uncertainties of tumour volumes on MRI of head and neck cancer patients

Ruta Zukauskaite, Christopher N. Rumley, Christian Rønn Hansen et al. · Clinical and Translational Radiation Oncology · 2022 · 14 citations · Full text